Terms: = Prostate cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Prognosis
12 results:
1. The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinoma.
Zhuo X; Dai H; Yu S
Medicine (Baltimore); 2022 Dec; 101(50):e31290. PubMed ID: 36550819
[TBL] [Abstract] [Full Text] [Related]
2. Radical prostatectomy or Observation for Clinically Localized prostate cancer: Extended Follow-up of the prostate cancer Intervention Versus Observation Trial (PIVOT).
Wilt TJ; Vo TN; Langsetmo L; Dahm P; Wheeler T; Aronson WJ; Cooperberg MR; Taylor BC; Brawer MK
Eur Urol; 2020 Jun; 77(6):713-724. PubMed ID: 32089359
[TBL] [Abstract] [Full Text] [Related]
3. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
[TBL] [Abstract] [Full Text] [Related]
4. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.
Weberpals J; Jansen L; van Herk-Sukel MPP; Kuiper JG; Aarts MJ; Vissers PAJ; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):1019-1031. PubMed ID: 28864947
[TBL] [Abstract] [Full Text] [Related]
5. EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression.
Satelli A; Batth I; Brownlee Z; Mitra A; Zhou S; Noh H; Rojas CR; Li H; Meng QH; Li S
Oncotarget; 2017 Jul; 8(30):49329-49337. PubMed ID: 28521303
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory prostate cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical Trial.
James ND; Pirrie SJ; Pope AM; Barton D; Andronis L; Goranitis I; Collins S; Daunton A; McLaren D; O'Sullivan J; Parker C; Porfiri E; Staffurth J; Stanley A; Wylie J; Beesley S; Birtle A; Brown J; Chakraborti P; Hussain S; Russell M; Billingham LJ
JAMA Oncol; 2016 Apr; 2(4):493-9. PubMed ID: 26794729
[TBL] [Abstract] [Full Text] [Related]
7. Vitamin D and prostate cancer prognosis: a Mendelian randomization study.
Trummer O; Langsenlehner U; Krenn-Pilko S; Pieber TR; Obermayer-Pietsch B; Gerger A; Renner W; Langsenlehner T
World J Urol; 2016 Apr; 34(4):607-11. PubMed ID: 26209090
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of combined general-epidural anesthesia with general anesthesia effects on survival and cancer recurrence: a meta-analysis of retrospective and prospective studies.
Pei L; Tan G; Wang L; Guo W; Xiao B; Gao X; Wang L; Li H; Xu Z; Zhang X; Zhao J; Yi J; Huang Y
PLoS One; 2014; 9(12):e114667. PubMed ID: 25548913
[TBL] [Abstract] [Full Text] [Related]
9. [Descriptive epidemiology of cancers in Cote d'Ivoire].
Effi AB; Koffi KE; Aman NA; Doukouré B; N'dah KJ; Koffi KD; Kouyaté M; Koui BB; Hondé M; Diomandé MI
Bull Cancer; 2013 Feb; 100(2):119-25. PubMed ID: 23406565
[TBL] [Abstract] [Full Text] [Related]
10. Scatter factor protects tumor cells against apoptosis caused by TRAIL.
Fan S; Meng Q; Laterra JJ; Rosen EM
Anticancer Drugs; 2010 Jan; 21(1):10-24. PubMed ID: 19823077
[TBL] [Abstract] [Full Text] [Related]
11. Reasonable delay of surgical treatment in men with localized prostate cancer--impact on prognosis?
Graefen M; Walz J; Chun KH; Schlomm T; Haese A; Huland H
Eur Urol; 2005 Jun; 47(6):756-60. PubMed ID: 15925069
[TBL] [Abstract] [Full Text] [Related]
12. Combining volume-weighted mean nuclear volume with Gleason score and clinical stage to predict more reliably disease outcome of patients with prostate cancer.
Fujikawa K; Sasaki M; Itoh T; Arai Y; Ogawa O; Yoshida O
Prostate; 1998 Oct; 37(2):63-9. PubMed ID: 9759699
[TBL] [Abstract] [Full Text] [Related]
